Loading...
PD-1/PD-L1 inhibitors in multiple myeloma: The present and the future
The introduction of PD-1/PD-L1 pathway inhibitors has marked a significant milestone in the treatment of various types of solid tumors. The current situation in multiple myeloma (MM) is rather unclear, as distinct research groups have reported discordant results. This discrepancy dominantly concerns...
Saved in:
| Published in: | Oncoimmunology |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2016
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5215080/ https://ncbi.nlm.nih.gov/pubmed/28123899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1254856 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|